Our CEO, Dr. Carmine Jabri, will be cohosting a webinar with Jan Flegeau, Director of Regulatory Affairs, to give an overview of what’s to come from the EU MDR.
A Biosimilar is essentially a biologic product that is similar and has no clinically significant difference in ...
